文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性肾脏病。

Chronic kidney disease.

机构信息

Division of Nephrology, Hypertension and Kidney Transplantation, University of California Irvine, Orange, CA, USA; Tibor Rubin Veterans Affairs Medical Center, Long Beach, CA, USA.

Duke-NUS Graduate Medical School, Singapore; Department of Renal Medicine, Singapore General Hospital, Singapore; Duke Global Health Institute, Durham, NC, USA.

出版信息

Lancet. 2021 Aug 28;398(10302):786-802. doi: 10.1016/S0140-6736(21)00519-5. Epub 2021 Jun 24.


DOI:10.1016/S0140-6736(21)00519-5
PMID:34175022
Abstract

Chronic kidney disease is a progressive disease with no cure and high morbidity and mortality that occurs commonly in the general adult population, especially in people with diabetes and hypertension. Preservation of kidney function can improve outcomes and can be achieved through non-pharmacological strategies (eg, dietary and lifestyle adjustments) and chronic kidney disease-targeted and kidney disease-specific pharmacological interventions. A plant-dominant, low-protein, and low-salt diet might help to mitigate glomerular hyperfiltration and preserve renal function for longer, possibly while also leading to favourable alterations in acid-base homoeostasis and in the gut microbiome. Pharmacotherapies that alter intrarenal haemodynamics (eg, renin-angiotensin-aldosterone pathway modulators and SGLT2 [SLC5A2] inhibitors) can preserve kidney function by reducing intraglomerular pressure independently of blood pressure and glucose control, whereas other novel agents (eg, non-steroidal mineralocorticoid receptor antagonists) might protect the kidney through anti-inflammatory or antifibrotic mechanisms. Some glomerular and cystic kidney diseases might benefit from disease-specific therapies. Managing chronic kidney disease-associated cardiovascular risk, minimising the risk of infection, and preventing acute kidney injury are crucial interventions for these patients, given the high burden of complications, associated morbidity and mortality, and the role of non-conventional risk factors in chronic kidney disease. When renal replacement therapy becomes inevitable, an incremental transition to dialysis can be considered and has been proposed to possibly preserve residual kidney function longer. There are similarities and distinctions between kidney-preserving care and supportive care. Additional studies of dietary and pharmacological interventions and development of innovative strategies are necessary to ensure optimal kidney-preserving care and to achieve greater longevity and better health-related quality of life for these patients.

摘要

慢性肾脏病是一种进行性疾病,无法治愈,发病率和死亡率高,常见于普通成年人群,尤其是糖尿病和高血压患者。保护肾功能可以改善预后,可以通过非药物策略(如饮食和生活方式调整)和针对慢性肾脏病和肾脏病特异性的药物干预来实现。植物性为主、低蛋白、低盐饮食可能有助于减轻肾小球高滤过,更长时间地保护肾功能,同时可能导致酸碱平衡和肠道微生物组的有利改变。改变肾内血液动力学的药物治疗(如肾素-血管紧张素-醛固酮系统调节剂和 SGLT2[SLC5A2]抑制剂)可以通过独立于血压和血糖控制降低肾小球内压来保护肾功能,而其他新型药物(如非甾体类盐皮质激素受体拮抗剂)可能通过抗炎或抗纤维化机制来保护肾脏。一些肾小球和囊性肾病可能受益于特定疾病的治疗。对于这些患者,管理慢性肾脏病相关心血管风险、最大限度降低感染风险和预防急性肾损伤是至关重要的干预措施,因为并发症负担高、相关发病率和死亡率高,以及非传统危险因素在慢性肾脏病中的作用。当需要进行肾脏替代治疗时,可以考虑逐步过渡到透析,这可能有助于更长时间地保留残余肾功能。保留肾脏的治疗和支持性治疗之间存在相似之处和区别。需要进一步研究饮食和药物干预措施,并开发创新策略,以确保提供最佳的保留肾脏的治疗,并为这些患者实现更长的寿命和更好的健康相关生活质量。

相似文献

[1]
Chronic kidney disease.

Lancet. 2021-8-28

[2]
Managing chronic kidney disease in diabetes patients with the latest chemical therapies.

Expert Rev Clin Pharmacol. 2018-12-3

[3]
Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.

Am J Physiol Renal Physiol. 2021-4-1

[4]
The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD.

Am J Kidney Dis. 2018-8-24

[5]
New pharmacological strategies for protecting kidney function in type 2 diabetes.

Lancet Diabetes Endocrinol. 2018-12-19

[6]
Analysis from the EMPA-REG OUTCOME trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.

Kidney Int. 2019-3-21

[7]
Aldosterone blockade in chronic kidney disease.

Semin Nephrol. 2014-5

[8]
Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.

Am J Nephrol. 2019-10-18

[9]
SGLT2 Inhibitors and the Diabetic Kidney.

Diabetes Care. 2016-8

[10]
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis.

Kidney Int. 2019-3-13

引用本文的文献

[1]
Quality of life in older immigrant adults on hemodialysis.

PLoS One. 2025-9-5

[2]
Combined effect of hyperhomocysteinemia and mild-to-moderate chronic kidney disease on mortality and cardiovascular events in the Japanese general population: the Yamagata (Takahata) study.

Clin Exp Nephrol. 2025-9-4

[3]
The role of N6-methyladenosine (mA) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential.

PeerJ. 2025-8-27

[4]
Prevalence and influencing factors of oral frailty among middle-aged and older patients with chronic kidney disease: a cross-sectional study.

Front Med (Lausanne). 2025-8-15

[5]
Call a spade a spade.

Hepatobiliary Surg Nutr. 2025-8-1

[6]
Safety and Short-Term Effects of Empagliflozin in Patients with Heart Failure and End-Stage Renal Disease.

Am J Cardiovasc Drugs. 2025-8-25

[7]
Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess.

Front Pharmacol. 2025-8-7

[8]
Glycolysis to lactylation: Unraveling the metabolic and epigenetic landscape in tissue fibrosis (Review).

Mol Med Rep. 2025-11

[9]
Salivary microbiome in peritoneal dialysis patients with and without sarcopenia: A pilot study.

PLoS One. 2025-8-22

[10]
Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines.

Ren Fail. 2025-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索